ESTEVE CDMO Invests $80M to Expand Manufacturing in China
- ESTEVE CDMO is investing over $80 million to expand and modernize its manufacturing operations in Shaoxing, China.
- The new facility will significantly increase manufacturing capacity, with over 400 cubic meters of total reaction volume available.
Operational Impact
This expansion allows ESTEVE CDMO to better serve its Asian customers while increasing its global manufacturing capacity.
Source: Contract Pharma Breaking News RSS